共 156 条
- [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 68 394-424
- [2] Ferlay J(2001)Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Gut. 48 251-259
- [3] Soerjomataram I(2020)Cancer statistics, 2020 CA Cancer J Clin. 70 7-30
- [4] Siegel RL(2019)Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion Am J Surg. 217 739-744
- [5] Torre LA(2015)Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis Oncotarget. 6 18151-18161
- [6] Jemal A(2015)Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis Adv Clin Exp Med. 24 331-340
- [7] Bolondi L(2015)Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis Clin Res Hepatol Gastroenterol. 39 458-468
- [8] Sofia S(2001)Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology. 33 1394-1403
- [9] Siringo S(2013)Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma Biomed Res Int. 2013 310427-463
- [10] Gaiani S(2002)Decision trees: an overview and their use in medicine J Med Syst. 26 445-248